PURPOSE: To evaluate the results of peeling of internal limiting membrane (ILM) for the treatment of diabetic macular edema with severe hard exudates. METHOD: We analyzed the records of the patients who had macular edema with severe hard exudates, underwent pars plana vitrectomy combined with indocyanine green (ICG)-assisted ILM peeling, and then were followed more than 4 months postoperatively. RESULTS: In 6 patients, 10 eyes, mean age was 60.2 years and follow-up period was 7.3 months. In all eyes, a attached posterior hyaloid was shown, and hard exudates and macular edema began to decrease within 1 week after operation. Visual acuity was less than 0.1 in 6 eyes before operation, in 3 eyes by the best visual acuity during follow-up period and in 4 eyes on the final examination, and 0.15 or better in 2 eyes, 6 eyes and 5 eyes, respectively. According to the best visual acuity, there was improvement in 8 eyes and no change in 2 eyes, and according to the final visual acuity, improvement in 6 eyes, no change in 3 eyes and deterioration in 1 eye. CONCLUSIONS: ICG-assisted ILM peeling would be helpful for the treatment of diabetic macular edema with severe hard exudates.
Exudates and Transudates* ; Follow-Up Studies ; Humans ; Indocyanine Green ; Macular Edema* ; Membranes* ; Visual Acuity ; Vitrectomy

For evaluating the reproductive performances of GTD patients, we found 115 cases of GTD patients, 77 HM and 38 GTT, who became pregnant after the completion of treatments and follow-up period. The results of this study suggest subsequent pregnancies after the completion of treatments may promise normal reproductive outcomes regardless of the chemotherapy.
Drug Therapy ; Follow-Up Studies ; Gestational Trophoblastic Disease* ; Humans ; Pregnancy

PURPOSE: To evaluate the mammographic and clinical findings of nonpalpable breast cancer. MATERIALS AND METHODS: In 28 of 607 breast cancer patients examined between January 1994 and April 1997, lesions werenonpalpable. We retrospectively analyzed the mammographic, clinical and pathologic features of 25 patients (28lesions) whose mammograms we obtained. RESULTS: Among these 25 patients (28 lesions) screening was abnormal in22; other symptoms were bloody nipple discharge(n=4), and nipple eczema(n=2). The patients were 34-62 (mean 52)years old. Invasive ductal carcinoma(n=13), DCIS(ductal carcinoma in situ, n-12), Paget's disease (n=2), andLCIS(lobular carcinoma in situ, n=1) were found during surgery. Six of 28 lesions(21%) showed evidence of axillarynodal metastasis;the majority arose from the upper outer quadrant of the breast (n=21). The mammographic findingswere mass (50%), (and mass with microcalcification, 11%); microcalcification(29%); asymmetrical density(14%); andnormal (7%). According to the mammographic density of breast parenchyma, the major finding in the low densitygroup(N1+P1) was mas (9/9), and in the high density group(P2+DY) was microcalcification (12/19). CONCLUSION: Themost common mammographic findings of nonpable breast cancer were mass (50%) and microcalcification(29%). Itsfeatures varied according to the mammographic density of breast parenchyma;mass was the main finding in the lowdensity group and microcalcification in the high density group.
Breast Neoplasms* ; Breast* ; Carcinoma in Situ ; Humans ; Mass Screening ; Nipples ; Retrospective Studies

Ovary is one of the organs in which angiogenesis occurs during ovarian cycle. Angiogenesis is associated with angiogenic factor like acidic fibroblast growth factor, basic fibroblast growth factor and transformation growth factor. Therefore, we performed this study to identify the distribution and mRNA expression of angiogenin, new potential angiogenic factor, in ovary of Korean native cattle by immunohistochemistry and in situ hybridization. Angiogenin immunoreactivity and mRNA expression were observed in endothelial cells, fibroblast and vascular smooth muscle cells. However, we could not observed angiogenin immunoreactivity and mRNA expression in primordial ovarian follicle. In follicular epithelial cells of primary ovarian follicle, weak angiogenin immunoreactivity and mRNA expression were observed. Follicular epithelial cells, theca interna and externa in secondary ovarian follicles, showed angiogenin immunoreactivity, while follicular epithelial cells did the weak mRNA expression. Angiogenin immunoreactivity and mRNA expression were observed in follicular epithlial cells, theca interna and oocyte in tertiary ovarian follicle. The corpus luteum showed strong immunoreactivity and mRNA expression but atretic follicle weak. However, these angiogenin immunoreactivity and mRNA expression became to be weaker during regression. These results suggest that angiogenin may play a role as not only an angiogenic factor but a growth factor in ovary.
Angiogenesis Inducing Agents ; Animals ; Cattle ; Corpus Luteum ; Endothelial Cells ; Epithelial Cells ; Female ; Fibroblast Growth Factor 1 ; Fibroblast Growth Factor 2 ; Fibroblasts ; Immunohistochemistry ; In Situ Hybridization ; Menstrual Cycle ; Muscle, Smooth, Vascular ; Oocytes ; Ovarian Follicle ; Ovary* ; RNA, Messenger* ; Theca Cells

Essential thrombocythemia, a subcategory of chronic myeloproliferative disorder, is characterized by absolute thrombocytosis due to excessive clonal proliferation of platelets, hyperaggregability of platelets and increased incidence of thrombosis and hemorrhage. Essential thrombocythemia may cause frequent vascular thrombosis, but it can be a rare cause of acute ischemic heart diseases such as acute myocardial infarction without atherosclerosis, unstable angina and angina pectoris. We report a case of essential thrombocythemia complicated by acute myocardial infarction. A patient with a previous history of vascular thrombotic complications (such as transient ischemic attack and deep vein thrombosis) was managed with 2.8 million units of intravenous urokinase, antiplatelet agent, ACEI, antianginal medications and hydroxyurea. There were clinically remarkable improvements and no further episodes of thrombotic ischemic vascular complications, including acute myocardial infarction.
Angina Pectoris ; Angina, Unstable ; Atherosclerosis ; Hemorrhage ; Humans ; Hydroxyurea ; Incidence ; Ischemic Attack, Transient ; Myeloproliferative Disorders ; Myocardial Infarction* ; Myocardial Ischemia ; Thrombocythemia, Essential* ; Thrombocytosis ; Thrombosis ; Urokinase-Type Plasminogen Activator ; Veins

PURPOSE: The cognitive and psychosocial morbidity of medically refractory epilepsy is considerable. Epilepsy surgery can play a important role in these patients. We investigated the clinical manifestations and the surgical outcome of our patients with medically refractory epilepsy. METHODS: We studied 27 patients under 15 years old who had epilepsy surgery at Samsung Medical Center between March 1995 and December 2001 retrospectively. RESULTS: The median age at first unprovoked seizure was 6 years, the median age at surgery was 11.02 years and duration of follow-up was 14 months to 7 years 2 months. Complex partial seizure was the most common type of seizures. Interictal and ictal discharges were lateralized in 66.7% and 81.5%, respectively. MRI showed abnormal findings in 23 patients and the cortical dysplasia was the most common pathologic finding. As per surgical outcomes, 77.8% of the patients became seizure free. Among patients with temporal lobe epilepsy(TLE), seizure free rate was 92.3% whereas patients with extratemporal lobe epilepsy(ETLE) showed 64.3% seizure free rate. All patients with TLE with focal lesions became seizure free. Patients with focal lesions which were concordant with findings of EEG, SPECT, and PET showed excellent surgical outcomes. However, patients with no focal lesion in MRI and discordant preoperative examinations showed poor outcomes. CONCLUSION: The results of epilepsy surgery in our patients were quite satisfactory. Good surgical outcome can be expected when the decision of surgery is made based on a good correlation among clinical, neuroradiological, and other preoperative examinations.
Adolescent ; Child ; Electroencephalography ; Epilepsy* ; Follow-Up Studies ; Humans ; Magnetic Resonance Imaging ; Malformations of Cortical Development ; Retrospective Studies ; Seizures ; Temporal Lobe ; Tomography, Emission-Computed, Single-Photon

OBJECTIVE: Uterine leiomyosarcoma (LMS) is a rare and aggressive disease with poor outcome. Due to its rarity and conflict of data, investigation on finding prognostic factor is challenging. The aim of the study was to investigate the prognostic significance of preoperative ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography/computed tomography (PET/CT) in uterine LMS. METHODS: This was a retrospective observational cohort study in 3 tertiary referral hospitals. We retrospectively evaluated data from patients with pathologically proven uterine LMS who underwent preoperative ¹⁸F-FDG PET/CT scans at 3 institutions. The prognostic implication of PET/CT parameters and other clinico-pathological parameters on disease-free survival (DFS) and overall survival (OS) was evaluated. RESULTS: Clinico-patholgical data were reviewed for 19 eligible patients. In the group overall, median DFS and OS were 12 and 20 months, respectively. As for the recurrence, large tumor size, and high tumor maximum standardized uptake value (SUVmax) were demonstrated as risk factors of recurrence. As for the OS, high tumor SUVmax was demonstrated as the unique risk factor. There were significant differences in tumor size, mitotic count, SUVmax, and DFS between patients with and without recurrence. Also, there were significant differences in tumor size, SUVmax, DFS, and OS between 2 subgroups stratified by cut-off SUVmax. CONCLUSION: SUVmax at preoperative ¹⁸F-FDG PET/CT was associated with worse outcome in patients with uterine LMS. In the preoperative setting, SUVmax can be a valuable non-invasive prognostic marker. Additionally, SUVmax can help identify highly aggressive uterine LMS and may help in adjusting standard treatment toward an individualized, risk-adapted treatment.
Cohort Studies ; Disease-Free Survival ; Electrons ; Fibrinogen ; Fluorodeoxyglucose F18 ; Humans ; Leiomyosarcoma* ; Positron-Emission Tomography and Computed Tomography* ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Factors ; Tertiary Care Centers ; Uterine Diseases

Leflunomide is a new disease modifying anti rheumatic drug (DMARD) for the treatment of active rheumatoid arthritis. Its mechanism of action differs from other DMARDs in that it inhibits the de novo pyrimidine synthesis by inhibiting dihydroorotate dehydrogenase and therefore prevents the proliferation of activated lymphocytes. As it has been prescribed worldwide, there is a great deal of much concerns regarding its potential adverse effects. Because leflunomide has an active metabolite with a long elimination half life of approximately 2 weeks, serious adverse reactions may occur even after the leflunomide treatment has been stopped. The profile of serious reactions includes liver dysfunction, hematological disorders, severe skin reactions and respiratory dysfunction. Respiratory dysfunctions with leflunomide therapy are very rare and its incidence is lower than that of methotrexate therapy. However, there are reports in Japan showing that 5 patients died of interstitial pneumonitis and another 11 patients developed serious lung complications associated with leflunomide. This suggests the possibility of fatal respiratory toxicity of leflunomide. There are no reports of interstitial pneumonitis associated with leflunomide in Korea. We report a case of a 62-year old woman who developed interstitial pneumonitis, which might have been induced by leflunomide during the treatment of rheumatoid arthritis.
Antirheumatic Agents ; Arthritis, Rheumatoid ; Female ; Half-Life ; Humans ; Incidence ; Japan ; Korea ; Liver Diseases ; Lung ; Lung Diseases, Interstitial* ; Lymphocytes ; Methotrexate ; Middle Aged ; Oxidoreductases ; Skin

Dieulafoy's lesions of the Jejunum are extremely rare. Therefore, localization of lesions is very difficult due to their small size and tendency of occasional bleeding. However, it is important to mention the location of the Dieulafoy's lesions to prevent excessive intestinal resections or, even worse, resection of the normal intestine. We report a case of preoperative localization of a Dieulafoy's lesion embolized by a metallic coil that allows a surgeon to accurately identify the bleeding, permitting a minimally invasive surgical treatment. A 25-year-old man presented with massive hematochezia. There was no definite bleeding focus on the upper gastrointestinal endoscopy and colonoscopy. An angiography found a persistent extravasation of the contrast media at the end of straight artery of the mid-jejunal branch, around the terminal ileum, embolized with metallic coils immediately. The combination of embolized metallic coils and intraoperative fluoroscopy allowed accurate identification and minimal laparotomy. Consequently, a highly selective and minimal resection of the jejunum containing the dieulafoy lesion was possible without any postoperative complications.
Adult ; Angiography* ; Arteries ; Colonoscopy ; Contrast Media ; Endoscopy, Gastrointestinal ; Fluoroscopy ; Gastrointestinal Hemorrhage ; Hemorrhage ; Humans ; Ileum ; Intestines ; Jejunum ; Laparotomy ; Postoperative Complications

Continuous electroencephalographic (EEG) monitoring is the widely used method of operative surveillance during carotid endarterectomy. EEG changes have been well known when cerebral ischemic event occurs during the carotid endarterectomy. But in our country intraoperative EEG monitoring during the operation was not popular and was not reported yet. We have experienced four patients showing EEG changes during the operation. EEG monitoring was performed using four channel differential montages in four patients with carotid artery disease. We evaluated the changes of EEG monitoring during the carotid endarterectomy. We also performed somatosensory evoked potentials (SEP) monitoring to backup the EEG monitoring which could miss the small embolic subcortical infarction. They revealed significant EEG changes which were the decreased fast activities and increased slowing during the carotid cross clamping. They were normalized after insertion of shunt. In one subject EEG change reappeared while the shunt was inserted, because the shunt was kinked, In all subjects, the significant changes of SEP were not observed after declamping of ICA or reposition of kinked shunt. There were not any immediate postoperative neurologic deficits in all patients. EEG monitoring might be considered as an useful method to detect ischemic changes during carotid endarterectomy and to know whether the inserted shunt is working well, Key Words : Intraoperative neuromonitoring, Carotid endarterectomy.
Carotid Artery Diseases ; Cerebral Infarction ; Constriction ; Electroencephalography ; Endarterectomy, Carotid* ; Evoked Potentials, Somatosensory ; Humans ; Neurologic Manifestations